Clinical Trials Directory

Trials / Completed

CompletedNCT05441852

A Study to Detect Hyperkalemia Using Smartphone-enabled Electrocardiogram (EKG)

Rapid dEtection of HyperkAlemia (K+) in the EmergenCy Department Using a SmarTphone-enabled Single-lead EKG (REACT)

Status
Completed
Phase
Study type
Observational
Enrollment
1,151 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
50 Years – 89 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to validate the real-world performance of a previously developed Artificial Intelligence - Electrocardiogram (AI-ECG) algorithm for identification of hyperkalemia with a six-lead mobile-enhanced device .

Detailed description

1. Ambulatory adult patients in the Emergency Department (ED) at increased risk for hyperkalemia (due to age ≥ 50 years, and one or more criteria including estimated Glomerular filtration rate (eGFR) (from serum creatinine) \< 45 ml/minute and/or a history of serum potassium \> 5.2 milliequivalents per liter (mEq/l) who present to the emergency department will be approached to consent for the rapid screening process. 2. Those who consent will undergo 30 second 6 L ECG recording with a portable, mobile-enhanced device (AliveCor Kardia). 3. This ECG data is subsequently evaluated by our artificial intelligence algorithm to detect hyperkalemia, and the estimated probability of hyperkalemia is recorded. 4. The research team notifies supervising Emergency Department staff of patients whose probability of hyperkalemia is significantly elevated above the optimized cutoff point according to the AI-ECG algorithm.

Conditions

Timeline

Start date
2022-03-31
Primary completion
2023-07-07
Completion
2023-07-07
First posted
2022-07-01
Last updated
2023-07-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05441852. Inclusion in this directory is not an endorsement.